| Recruiting | A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT Adenovirus Infections | Phase 3 | 2026-02-15 |
| Suspended | A Phase 1b/2 Study of Intravenous Brincidofovir in Patients With Relapsed or Refractory Lymphoma and Relapsed Relapsed or Refractory Lymphoma Including ENKL | Phase 1 / Phase 2 | 2025-06-09 |
| Terminated | Study to Confirm of the Safety and Tolerability of Brincidofovir in Subjects With BK Virus Infection (Viremia) BK Virus Infection, Nephropathy, Kidney Transplantation | Phase 2 | 2022-10-14 |
| Recruiting | A Phase 2a Study of IV BCV in Subjects With Adenovirus Infection Adenovirus Infections, Cytomegalovirus Infection | Phase 2 | 2021-08-16 |
| Completed | Drug-Drug Interaction Study of Intravenous Administration of SyB V-1901 and Cyclosporine in Japanese Healthy S Drug Drug Interaction | Phase 1 | 2020-11-09 |
| Completed | Follow-up Study of SyB L-0501 in Combination With Rituximab to Treat DLBCL Diffuse Large B Cell Lymphoma | — | 2020-03-26 |
| Completed | Phase I/II Study of SyB L-0501RI in Combination With Rituximab to Treat Lymphoma Lymphoma, B-cell, Diffuse | Phase 1 / Phase 2 | 2019-04-01 |
| Completed | SyB C-0501(Oral Bendamustine) in Patients With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 | 2018-05-24 |
| Completed | Phase III Study of SyB L-0501 in Combination With Rituximab to Treat Recurrent/Relapsed Diffuse Large B-Cell L Assess the Efficacy and Safety of SyB L-0501 in Combination With Rituximab in Patients With Recurrent or Relapsed DLBCL | Phase 3 | 2018-01-15 |
| Completed | Study of SyB C-1101 in Patients With Myelodysplastic Syndrome Myelodysplastic Syndrome | Phase 1 | 2017-10-06 |
| Terminated | Study of SyB P-1501 (Fentanyl HCI) for Treatment of Postoperative Pain Postoperative Pain | Phase 3 | 2016-11-21 |
| Withdrawn | Combination Therapy of SyB C-1101 and Azacytidine in Patients With Myelodysplastic Syndrome Myelodysplastic Syndrome | Phase 1 | 2015-12-01 |
| Completed | Long Term Safety Study of SyB L-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrom Myelodysplastic Syndrome | Phase 1 | 2014-12-01 |
| Completed | Long Term Safety Study of SyB C-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrom Myelodysplastic Syndrome | Phase 1 | 2013-08-01 |
| Completed | Safety and Pharmacokinetics Study of SyB C-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplas Myelodysplastic Syndrome | Phase 1 | 2013-03-01 |
| Completed | Efficacy and Safety Study of SyB L-0501 for Patients With Chronic Lymphocytic Leukemia Chronic Lymphocytic Leukemia | Phase 2 | 2013-01-01 |
| Completed | Safety and Pharmacokinetics Study of SyB L-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplas Myelodysplastic Syndrome | Phase 1 | 2012-06-01 |
| Completed | Efficacy and Safety Study of SyB L-0501 in Combination With Rituximab in Patients With Untreated, Low-grade B Low-grade B Cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma Where Hematopoietic Stem Cell Transplantation is Not Indicated | Phase 2 | 2011-11-01 |
| Completed | Study of SyB L-0501 to Treat Relapsed/Refractory Multiple Myeloma Relapsed/Refractory Multiple Myeloma | Phase 2 | 2011-11-01 |
| Completed | Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV) Radiotherapy-induced Nausea and Vomiting (RINV) | Phase 2 | 2011-05-01 |
| Terminated | Efficacy and Safety Study of SyB L-0501 for Patients With Multiple Myeloma Multiple Myeloma | Phase 2 | 2010-09-01 |
| Completed | Study of SyB L-0501 in Combination With Rituximab to Treat Relapsed/Refractory Diffuse Large B-Cell Lymphoma Non-Hodgkin's Lymphoma, Lymphoma, Large Cell, Diffuse, Mantle Cell Lymphoma, Lymphoma | Phase 2 | 2010-04-01 |
| Completed | A Phase I Clinical Trial of SyB L-0501 in Combination With Rituximab to Patients With Aggressive B-cell Non-Ho Non-Hodgkin's Lymphoma, Diffuse Large B-Cell Lymphoma, Mantle Cell Lymphoma | Phase 1 | 2008-11-01 |
| Completed | Clinical Study on SyB L-0501 in Patients With Indolent B-cell Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma | Phase 2 | 2007-12-01 |
| Completed | A Phase I Study of Bendamustine Hydrochloride in Patients With Indolent B-cell Non-Hodgkin's Lymphoma Non-Hodgkin's Lymphoma | Phase 1 | 2006-10-31 |